This grant opportunity (PAR-26-091) from the NIH seeks proposals for assay validation of high-quality markers for clinical studies in cancer. UH2/UH3 clinical trials are not allowed under this funding opportunity.
Want the full details?
Sign up free to see the agency name, contact info, and the original bid posting link.